Abstracts

Outcome of a Multidimensional Intervention for Insomnia in a Cohort of People Living With HIV

Background: No studies specifically assessed interventions for improving sleep quality (SQ) in people with HIV (PWH). We introduced a multidimensional program for SQ in the routine management at our outpatient clinic and assessed its impact on PWH suffering from insomnia. Methods: Interventional study in adult PWH with subthreshold (≥8), moderate (≥15), or severe (≥22) insomnia…

Transcriptomics and Proteomics Reveal Differential Pathways in DTG/3TC vs 3DR Regimens in PLHIV

Background: Drug toxicity in people living with HIV (PLHIV) using cART is a concern. Nucleoside analogues are associated with mitochondrial damage. Two-drug regimens (2DR), such as DTG (integrase strand inhibitor) and 3TC may reduce drug toxicity, but the molecular effects remain unclear. Systemic effects of DTG/3TC and triple therapies (3DR) were studied using multi-omics. Methods:…

Effects of Semaglutide on Muscle Structure and Function in the SLIM Liver Study

Background: Semaglutide, a GLP-1 receptor agonist, is a highly effective medication for decreasing weight and weight complications by suppressing appetite, improving insulin signaling, and reducing intrahepatic triglycerides (IHTG). However, concomitant loss of muscle mass often accompanies weight loss, which may have consequences on muscle function. The purpose of this analysis was to examine changes in…

Weight Gain After Initiating ART Close to HIV Seroconversion: Is There a Return to Health Effect?

Background: Findings from seroprevalent cohorts suggest that weight gain after ART initiation is greater with regimens containing Integrase Strand Transfer Inhibitors (INSTI) than with other antiretrovirals. We investigate weight trends among individuals initiating ART within one year of seroconversion (SC). Methods: Included individuals from the CASCADE Collaboration seroconverted 1997-2022, were ≥16 years, had HIV- to…

Proteomic Signature of HIV-Associated Myocardial Fibrosis and Incident Heart Failure

Background: Persons living with HIV (PLWH) receiving antiretroviral therapy (ART) have greater myocardial fibrosis compared to persons without HIV (PWOH), which may contribute to risk of heart failure (HF). Mechanisms remain unclear but hypotheses include accentuated aging linked to chronic immune activation. We identified plasma proteomic signatures elevated among PLWH, cross-sectionally associated with myocardial fibrosis,…